These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Thrombotic Microangiopathy With Granulomatosis Interstitial Nephritis in an Allogenic Bone Marrow Transplant Patient: A Case Report and Review of the Literature. Mirza AS; Verma S; Fu L; Bassil C J Hematol; 2017 Sep; 6(2-3):52-58. PubMed ID: 32300393 [TBL] [Abstract][Full Text] [Related]
30. Hemolytic-uremic syndrome caused by gemcitabine. Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169 [No Abstract] [Full Text] [Related]
31. Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report. Facchini L; Lucchesi M; Stival A; Roperto RM; Melosi F; Materassi M; Farina S; Tintori V; de Martino M; Sardi I J Med Case Rep; 2017 Jul; 11(1):209. PubMed ID: 28747219 [TBL] [Abstract][Full Text] [Related]
32. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature. Burns ST; Damon L; Akagi N; Laszik Z; Ko AH Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643 [TBL] [Abstract][Full Text] [Related]
34. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer. Mazzanti P; Massacesi C; Rocchi MB; Mattioli R; Lippe P; Trivisonne R; Buzzi F; De Signoribus G; Tuveri G; Rossi G; Di Lullo L; Sturba F; Morale D; Catanzani S; Pilone A; Bonsignori M; Battelli T Lung Cancer; 2003 Jul; 41(1):81-9. PubMed ID: 12826316 [TBL] [Abstract][Full Text] [Related]
35. Delayed anemia and thrombocytopenia after treatment with gemcitabine. Malayeri R; Krajnik G; Ohler L; Pirker R J Natl Cancer Inst; 1997 Aug; 89(15):1164. PubMed ID: 9262256 [No Abstract] [Full Text] [Related]
36. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO). Tibaldi C; Ricci S; Russo F; Bernardini I; Galli L; Chioni A; Orlandini C; Grosso AM; Pegna AL; Fabbri A; Innocenti F; Ferrari K; Tognarini L; Conte PF; Falcone A; Lung Cancer; 2005 Apr; 48(1):121-7. PubMed ID: 15777979 [TBL] [Abstract][Full Text] [Related]
37. [Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature]. Dilhuydy MS; Delclaux C; Pariente A; De Precigout V; Aparicio M Rev Med Interne; 2002 Feb; 23(2):189-92. PubMed ID: 11876063 [TBL] [Abstract][Full Text] [Related]
38. [Gemcitabine-induced thrombotic microangiopathy: Can we improve screening and treatment?]. Charmetant X; Jolivot A; Fournier T; Puthet JC; Cassier P; Lemoine S; Juillard L Nephrol Ther; 2017 Jun; 13(4):251-254. PubMed ID: 28499586 [TBL] [Abstract][Full Text] [Related]
39. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine]. Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557 [TBL] [Abstract][Full Text] [Related]
40. Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis. Zhang X; Lu J; Xu J; Li H; Wang J; Qin Y; Ma P; Wei L; He J Respirology; 2013 Jan; 18(1):131-9. PubMed ID: 22882698 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]